Bayer And NextRNA Partner On New Small Molecule Cancer Drugs

Bayer and NextRNA Therapeutics, a biotechnology company, announced that they would be working together to create a new type of small molecule cancer drug. The two companies agreed to a deal that could be worth over $500 million. The two companies will use NextRNA’s technology to move forward with two small molecule drugs that target […]

GSKs Lung Cancer ADC Earns FDA Breakthrough Designation

The FDA has granted breakthrough status to an antibody-drug conjugate (ADC) that GSK licensed from China’s Hansoh Pharma in a $1.7 billion agreement last year. The pharma firm said that GSK5764227 (GSK’227, formerly known as HS-20093) has been granted the coveted designation for the use of the ADC to treat relapsed or refractory extensive-stage small-cell […]

Nuclear Medicine In North America: Market Growth & Trends

The North American nuclear medicine market was estimated to be worth USD 2.05 billion in 2023 and is expected to develop rapidly over the next few years, with a compound annual growth rate (CAGR) of 9.90% through 2029. Within the healthcare sector, the nuclear medicine market is a vibrant and quickly developing area. It includes […]

Bayer & NextRNA Partner In $547Million Cancer Therapy Deal

This summer, Bayer officials made sure Fierce understood that the company’s desire for deals hasn’t been stifled by a group-wide reorganization. Its most recent partnership aimed at treating cancer indicates that Bayer has, in fact, not lost interest in novel and exciting approaches. An agreement for over half a billion biobucks was inked by the […]

Get Ready, Pharma: Drug Supply Chain Security Act (DSCSA) Enforcement Is At Hand

More than 10 years ago, Congress passed a law designed to protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. Up until now, it has never been fully enforced because drug manufacturers and distributors kept making the case that they lacked the capacity and the software capabilities to come […]

AI not just for data crunching but better patient outcomes – Dominic Marasco from Envision Pharma Group

In Conversation with Dominic Marasco: AI Beyond Data Crunching for Better Patient Outcomes In this exclusive interview with World Pharma Today, Dominic Marasco, a leader at Envision Pharma Group, delves into the transformative role of artificial intelligence (AI) in the pharmaceutical industry. While AI is often celebrated for its data-crunching capabilities, Marasco sheds light on […]

Introducing ReciPredict: Revolutionising Drug Product Development and Manufacturing

Recipharm announced the launch of ReciPredict, a cutting-edge platform for Quality by Design (QbD), designed to transform the landscape of drug product development, tech transfer and manufacturing. With its innovative combination and systematic application of material sciences, statistical tools and modelling and simulation, ReciPredict promises to deliver unparalleled efficiency and reliability to the pharmaceutical industry, […]

Lonza Completes Expansion of Microbial Manufacturing Facility in Visp

Lonza, a global partner to the pharmaceutical, biotech, and nutraceutical markets, announced that it has completed a planned expansion of the mid-scale microbial manufacturing facility at its Visp (CH) site. This multi-product facility was recently granted a GMP license after a successful audit by Swissmedic, allowing cGMP manufacturing and release of biologics produced using microbial […]

Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair

Coronado Research is a consultancy-led, professional services organisation operating in the clinical development arena. The company will help pharmaceutical and biotechnology companies optimise their drug development programs by maximising the use of data and technology, and by joining the dots from Regulatory Strategy to Market Access. MacGarvey said, “I am delighted to launch Coronado Research, a […]

CPHI Milan Announce Pharma Award finalists

CPHI Milan (8-10 October, 2024) announces the finalists for the upcoming CPHI Pharma Awards, which will be hosted on the event’s opening evening at the CPHI Celebration. The awards are a key feature of the ‘CPHI Celebration’ and will commence with a glamorous drinks reception, celebrating excellence and innovation in the pharmaceutical industry across 14 categories. Among the highlights are two new awards. First, […]